Julie Elaine Burke

Array ( [id] => 3977685 [patent_doc_number] => 05948647 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-07 [patent_title] => 'Nucleic acids encoding antigen-binding sites specific for cancer antigens' [patent_app_type] => 1 [patent_app_number] => 8/484508 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21556 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/948/05948647.pdf [firstpage_image] =>[orig_patent_app_number] => 484508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4083226 [patent_doc_number] => 06025143 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'Antibodies directed against peptides derived from the SMR1 polypeptide' [patent_app_type] => 1 [patent_app_number] => 8/476120 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 4694 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/025/06025143.pdf [firstpage_image] =>[orig_patent_app_number] => 476120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3636135 [patent_doc_number] => 05631351 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-20 [patent_title] => 'Antibodies to MDC proteins' [patent_app_type] => 1 [patent_app_number] => 8/477407 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 16348 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/631/05631351.pdf [firstpage_image] =>[orig_patent_app_number] => 477407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3928771 [patent_doc_number] => 05972353 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'MN proteins, polypeptides, fusion proteins and fusion polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/477504 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 41 [patent_no_of_words] => 42335 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972353.pdf [firstpage_image] =>[orig_patent_app_number] => 477504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4225349 [patent_doc_number] => 06011139 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-04 [patent_title] => 'Hybridomas and monoclonal antibodies that specifically bind to glutamic acid decarboxylase peptides' [patent_app_type] => 1 [patent_app_number] => 8/483952 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 18 [patent_no_of_words] => 27339 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/011/06011139.pdf [firstpage_image] =>[orig_patent_app_number] => 483952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3986090 [patent_doc_number] => 05959084 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-28 [patent_title] => 'Bispecific antibodies, methods of production and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/480527 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 14742 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/959/05959084.pdf [firstpage_image] =>[orig_patent_app_number] => 480527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3659798 [patent_doc_number] => 05648260 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-15 [patent_title] => 'DNA encoding antibodies with altered effector functions' [patent_app_type] => 1 [patent_app_number] => 8/478825 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 6227 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/648/05648260.pdf [firstpage_image] =>[orig_patent_app_number] => 478825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3682802 [patent_doc_number] => 05695758 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Monoclonal antibodies against tumor-associated antigens, processes for the preparation thereof and the use thereof' [patent_app_type] => 1 [patent_app_number] => 8/478857 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 18 [patent_no_of_words] => 3933 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/695/05695758.pdf [firstpage_image] =>[orig_patent_app_number] => 478857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4184705 [patent_doc_number] => 06093548 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-25 [patent_title] => 'Detection and quantitation of MN-specific antibodies.' [patent_app_type] => 1 [patent_app_number] => 8/485863 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 59 [patent_no_of_words] => 42483 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/093/06093548.pdf [firstpage_image] =>[orig_patent_app_number] => 485863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3939730 [patent_doc_number] => 05989838 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Immunological methods of detecting MN proteins and MN polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/485862 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 58 [patent_no_of_words] => 42055 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/989/05989838.pdf [firstpage_image] =>[orig_patent_app_number] => 485862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3943109 [patent_doc_number] => 05981711 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'MN-specific antibodies and hybridomas' [patent_app_type] => 1 [patent_app_number] => 8/486756 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 58 [patent_no_of_words] => 42420 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981711.pdf [firstpage_image] =>[orig_patent_app_number] => 486756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4213570 [patent_doc_number] => 06087117 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Production and use of human nm23 protein and antibodies therefor' [patent_app_type] => 1 [patent_app_number] => 8/475684 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 11 [patent_no_of_words] => 7947 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/087/06087117.pdf [firstpage_image] =>[orig_patent_app_number] => 475684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3943692 [patent_doc_number] => 05955075 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Method of inhibiting tumor growth using antibodies to MN protein' [patent_app_type] => 1 [patent_app_number] => 8/481658 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 58 [patent_no_of_words] => 42093 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955075.pdf [firstpage_image] =>[orig_patent_app_number] => 481658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3733065 [patent_doc_number] => 05693761 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-02 [patent_title] => 'Polynucleotides encoding improved humanized immunoglobulins' [patent_app_type] => 1 [patent_app_number] => 8/474040 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 80 [patent_no_of_words] => 45111 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/693/05693761.pdf [firstpage_image] =>[orig_patent_app_number] => 474040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3949737 [patent_doc_number] => 05977323 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Method of purifying Gro .beta. or Gro .alpha. protein using antibodies' [patent_app_type] => 1 [patent_app_number] => 8/477675 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 14229 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/977/05977323.pdf [firstpage_image] =>[orig_patent_app_number] => 477675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4290651 [patent_doc_number] => 06180370 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-30 [patent_title] => 'Humanized immunoglobulins and methods of making the same' [patent_app_type] => 1 [patent_app_number] => 8/484537 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 80 [patent_no_of_words] => 38961 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/180/06180370.pdf [firstpage_image] =>[orig_patent_app_number] => 484537 [rel_patent_id] =>[rel_patent_doc_number] =>)